Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
Apply
Botensilimab & Balstilimab
RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step